The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Next-Generation Antibody Therapeutics Global Market Report 2023, the next-generation antibody therapeutics market is expected to show significant growth in the forecast period.

Key insights from the next-generation antibody therapeutics market forecast include:

1. Market Size

The global next-generation antibody therapeutics market is expected to grow from $5.44 billion in 2022 to $6.14 billion in 2023 at a compound annual growth rate (CAGR) of 12.8%. The next-generation antibody therapeutics market is expected to reach $9.43 billion in 2027 at a CAGR of 11.3%.

2. Major Driver

The increasing prevalence of chronic diseases is expected to propel the growth of the next-generation antibody therapeutics market going forward. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, it was projected that by the year 2050, the number of individuals aged 50 years and older who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, the increasing prevalence of chronic diseases is driving the growth of the next-generation antibody therapeutics market.

View More On The Next-Generation Antibody Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/next-generation-antibody-therapeutics-global-market-report

3. Key Trend

Technological advancements are a key trend gaining popularity in the next-generation antibody therapeutics market. Major companies operating in the next-generation antibody therapeutics market are concentrating on creating technologically advanced products to strengthen their position in the market. For instance, in October 2021, Merck KGaA, a Germany-based science and technology company, launched the new technology ChetoSensar. By addressing solubility issues, ChetoSensar offers renewed hope for antibody-drug conjugates. It has improved the efficacy of its antibody-drug conjugates and high-potency active pharmaceutical ingredient (HPAPI). By enhancing the solubility of antibody-drug conjugates, the novel ChetoSensar technology expands the potential for developing next-generation antibody-drug conjugate therapeutics.

4. Largest Region

North America was the largest region in the next-generation antibody therapeutics market in 2022.

5. Major Players

Major players in the next-generation antibody therapeutics market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Celgene Corporation, Lonza Group AG, Catalent Inc., Genentech Inc., Kyowa Hakko Kirin Co. Ltd., Samsung Biologics, WuXi Biologics, Seagen Inc., Seattle Genetics Inc., Xencor Inc., and ImmunoGen Inc

Request A Sample Of The Global Next-Generation Antibody Therapeutics Market Report 2023:

https://www.thebusinessresearchcompany.com/sample_request?id=12678&type=smp

Key Next-Generation Antibody Therapeutics Market Segments

The global next-generation antibody therapeutics market is segmented –

1) By Types Of Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Biospecific Antibodies, Antibody-Drug Conjugates, Other Types

2) By Therapeutic Area: Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, Other Therapeutic Areas

3) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

The Next-Generation Antibody Therapeutics Global Market Report 2023 provides an in-depth analysis on the next-generation antibody therapeutics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the next-generation antibody therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –

Next Generation Sequencing Global Market Report 2023

Leukemia Therapeutics Global Market Report 2023

Antisense & RNAi Therapeutics Global Market Report 2023

Contact us at:

The Business Research Company:https://www.thebusinessresearchcompany.com/

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn:https://in.linkedin.com/company/the-business-research-company
YouTube:https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model:https://www.thebusinessresearchcompany.com/global-market-model